SEC Comment Letter 0000000000-23-005853 to China SXT Pharmaceuticals, Inc. (SXTC) (CIK 0001723980) (SXTC)
China SXT Pharmaceuticals, Inc. (SXTC) (CIK 0001723980)
Date: June 2, 2023 · CIK: 0001723980 · Accession: 0000000000-23-005853
AI Filing Summary & Sentiment
File numbers found in text: 001-38773
Letter
United States securities and exchange commission logo June 2, 2023 Feng Zhou Chief Executive Officer China SXT Pharmaceuticals, Inc. 178 Taidong Rd North Taizhou Jiangsu, China Re:China SXT Pharmaceuticals, Inc. Form 20-F for the Fiscal Year Ended March 31, 2022 Filed July 18, 2022 File No. 001-38773 Dear Feng Zhou: We have completed our review of your filings. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences
Show Raw Text
United States securities and exchange commission logo
June 2, 2023
Feng Zhou
Chief Executive Officer
China SXT Pharmaceuticals, Inc.
178 Taidong Rd North
Taizhou Jiangsu, China
Re:China SXT Pharmaceuticals, Inc.
Form 20-F for the Fiscal Year Ended March 31, 2022
Filed July 18, 2022
File No. 001-38773
Dear Feng Zhou:
We have completed our review of your filings. We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences